share_log

新興市場銘柄ダイジェスト:colyは一時ストップ高、ステラファーマが大幅に続伸

Emerging markets stock digest: Coly briefly hit the limit up, Stella Pharma continued to rise significantly.

Fisco Japan ·  Jun 5 14:26

<4175> coly 1436 +147

Temporary stoppage. The female-oriented mobile game "Break My Case" has reportedly risen sharply in the AppStore app sales ranking, and is considered a buying factor. According to the same site, the ranking was below 200 until the previous day, but rose to 32nd on the 5th. Break My Case is a game that combines music and matching puzzles. Players can enjoy stories with male characters as the owner representative of a cafe bar.

<4893> No Il Immune 145 + 11

Sharp continued rise. They have announced that the results of the Phase 1 clinical trial for their self-produced CAR-T cell therapy (NIB102), which targets solid tumors, were reported at the Annual Meeting of the American Society of Clinical Oncology. They found that there were no observed dose-limiting toxicities, and suggested that there was efficacy, with anti-tumor effects observed in liver cancer patients and tumors shrinking. In the future, after receiving the rights to develop and commercialize from Takeda Pharmaceutical Co., Ltd. <4502>, Noile-Immune Biotech will take the lead in development.

<5597> BlueInno 984 +65

Kyushu Electric Power's subsidiary, Kyuden Drone Service (Fukuoka City, Fukuoka Prefecture), has announced that it has signed a strategic technical partnership MOU with a significant increase. The aim is to improve the efficiency of indoor infrastructure inspection using drones and robots, and to develop new inspection services. In addition, it has signed strategic partnership MOUs with domestic drone manufacturers such as ACSL <6232> towards the establishment of type-specific drone operator-qualification and operation certification, and it has also revealed its responsibility for the facility supervision and operation of the Tokyo's first logistics facility-type drone verification and testing field.

<4894> Qualips 5300 +150

Sell ​​ahead and recover. Tokyo Stock Exchange strengthened regulatory measures regarding margin trading from the 5th, causing selling pressure due to the perception of squeezing trading. The commission guarantee deposit rate for new selling and buying is now over 50% (including 20% or more in cash). TOCOM is also implementing an additional margin requirement collection measure. The battle between buyers and sellers continued around the level of 5,000 yen, as the Qualips' shares have been pushed down by profit-taking since reaching a record high on May 30th.

<4888> Stella Pharma 386 +35

Significant continued rise due to receipt of a 1 billion yen guarantee from Pengbo, a Chinese company, for the introduction of Boron Neutron Capture Therapy (BNCT, a type of radiation therapy for cancer) to China's Hainan Island Medical Special Zone. Stella Pharma has already signed a basic agreement with Pengbo and other companies regarding the supply of boron medicines for BNCT. The Hainan Island Medical Special Zone project is progressing smoothly toward the start of treatment from April to June 2025, and Stella Pharma is also preparing for the supply of Steboronin.

<5242> Eyes 1896 +4

Rebound. They have announced that they have successfully improved the display speed of the management screen of the Media Radar, an advertising industry platform, to the fastest 0.1 seconds. Media Radar is a search site for the advertising industry that connects marketing personnel, advertising agencies, media companies, and marketing service companies. In addition to improving the management screen, the 200-day moving average line is also being perceived as a lower limit support line, which seems to lead to buying.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment